Voyager Therapeutics, Inc.

US$1.86As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:VYGRHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (16.95%)
Div yield —
ROE (58.90%)
Biotechnology
Beta (5Y) 1.17
PE TTM —
TSR TTM (60.06%)
Mkt cap US$116.1M
ROIC (169.24%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.25
20.64%
(47.63%)
Hold 9|2|8|8|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
15.83%
3.31%
13.07%
11.55%
Revenue$M
7.117
7.373
7.447
7.634
1.22%
4.95%
5.96%
6.14%
Peers (US$116.1M)
Cap (US$)
PE
118.3M
—
Capital
TTM
5Y
10Y
Leveragex
0.389
0.064
0.054
EBIT/Intx
0.453
0.885
0.842
Own earn%
(127.35)
70.53
68.81
Sh yield%
39.57
33.69
36.98
Owners
Insiders/Inst%
12.42
41.18
Short interest%
1.33
SBC / revenue%
4.73
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
12–17
$1 testx
—
Incr. ROIC%
38